SE400296B - Forfarande for framstellning av derivat av cyklisk adenosin-3',5'-monofosforsyra - Google Patents

Forfarande for framstellning av derivat av cyklisk adenosin-3',5'-monofosforsyra

Info

Publication number
SE400296B
SE400296B SE7013709A SE1370970A SE400296B SE 400296 B SE400296 B SE 400296B SE 7013709 A SE7013709 A SE 7013709A SE 1370970 A SE1370970 A SE 1370970A SE 400296 B SE400296 B SE 400296B
Authority
SE
Sweden
Prior art keywords
procedure
preparation
acid derivatives
adenosin
cyclic
Prior art date
Application number
SE7013709A
Other languages
English (en)
Inventor
G Cehovic
A Gabbai
I Marcus
T Posternak
Original Assignee
Anvar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR6934747A external-priority patent/FR2068728A1/fr
Priority claimed from FR7035682A external-priority patent/FR2112084A1/fr
Application filed by Anvar filed Critical Anvar
Publication of SE400296B publication Critical patent/SE400296B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7013709A 1969-10-10 1970-10-09 Forfarande for framstellning av derivat av cyklisk adenosin-3',5'-monofosforsyra SE400296B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR6934747A FR2068728A1 (en) 1969-10-10 1969-10-10 Cyclic (iso)adenosine-3' 5'-monophosphoric - acid derivs
FR7035682A FR2112084A1 (en) 1970-10-02 1970-10-02 Cyclic (iso)adenosine-3' 5'-monophosphoric - acid derivs

Publications (1)

Publication Number Publication Date
SE400296B true SE400296B (sv) 1978-03-20

Family

ID=26215308

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7013709A SE400296B (sv) 1969-10-10 1970-10-09 Forfarande for framstellning av derivat av cyklisk adenosin-3',5'-monofosforsyra
SE7314163A SE412240B (sv) 1969-10-10 1973-10-18 Forfarande for framstellning av cykliska adenosinfosforsyraderivat

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE7314163A SE412240B (sv) 1969-10-10 1973-10-18 Forfarande for framstellning av cykliska adenosinfosforsyraderivat

Country Status (7)

Country Link
US (1) US3856776A (sv)
JP (1) JPS5022559B1 (sv)
CA (1) CA979890A (sv)
CH (1) CH531009A (sv)
DE (1) DE2049638A1 (sv)
GB (1) GB1336441A (sv)
SE (2) SE400296B (sv)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4911896A (sv) * 1972-05-15 1974-02-01
DE2401449A1 (de) * 1973-01-16 1974-07-25 Voorhees Pharmazeutische zusammensetzung zur linderung von hautproliferationserkrankungen
DE2401454A1 (de) * 1973-01-16 1974-07-18 John James Voorhees Pharmazeutische zusammensetzung zur behandlung von hautproliferationserkrankungen
GB1441706A (en) * 1973-04-06 1976-07-07 Yamasa Shoyu Kk Crystalline monosodium n6, 2-o-dibutyryl-adenosine-3-5-cyclic monophosphate and production thereof
IT1059679B (it) * 1974-04-02 1982-06-21 Marxer Spa Sali di d-glucosammina ad azione terapeutica
JPS50142595A (sv) * 1974-05-14 1975-11-17
GB1504891A (en) * 1974-05-31 1978-03-22 Icn Pharmaceuticals Purine nucleotides
JPS5176292A (en) * 1974-12-27 1976-07-01 Asahi Chemical Ind 88 arukiruaminoadenoshin 365** kanjomonorinsanesuterumatahasonoennoseizohoho
JPS5141389A (ja) * 1974-10-03 1976-04-07 Asahi Chemical Ind Saikuritsukuadenoshinmonohosufueitojudotaino seiho
US3988442A (en) * 1975-07-16 1976-10-26 Nelson Research & Development Company Cyclic nucleotide derivatives for treatment of hypothyroidism
FR2358155A1 (fr) * 1976-07-15 1978-02-10 Lapinet Eugene Composition pour le traitement et la prevention de l'irritation et de l'inflammation de la peau, de l'oeil et des muqueuses
US4567254A (en) * 1984-09-19 1986-01-28 Kikkoman Corporation Method for preparing N6,8-disubstituted 3',5'-cyclic adenosine monophosphate and salt thereof
US4956348A (en) * 1986-02-19 1990-09-11 Eye Research Institute Of Retina Foundation Stimulation of tear secretion with cyclic nucleotides
JPS63208525A (ja) * 1987-02-25 1988-08-30 Kikkoman Corp 心不全治療剤
US6919320B1 (en) 1987-10-28 2005-07-19 Wellstat Therapeutics Corporation Pharmaceutical compositions containing deoxyribonucleosides for wound healing
US5246708A (en) * 1987-10-28 1993-09-21 Pro-Neuron, Inc. Methods for promoting wound healing with deoxyribonucleosides
US6348451B1 (en) 1987-10-28 2002-02-19 Pro-Neuron, Inc. Acyl deoxyribonucleoside derivatives and uses thereof
WO1989005647A1 (en) * 1987-12-21 1989-06-29 Nucleic Acid Research Institute Treatment of malignant tumors with 8-aminoadenosine 3',5'-cyclic phosphate and combinations of 8-aminoadenosine 3',5'-cyclic phosphate and 8-chloroadenosine 3',5'-cyclic phosphate
ZA892928B (en) * 1988-04-25 1991-01-30 Pro Neuron Inc Pharmaceutical compositions containing deoxyribonucleosides for wound healing
CA1335572C (en) * 1988-05-23 1995-05-16 Yoon Sang Cho-Chung Derivatives of cyclic amp as treatment for cancer
US7169765B1 (en) 1988-10-27 2007-01-30 Wellstat Therapeutics Corporation Acyl deoxyribonucleoside derivatives and uses thereof
JP2640980B2 (ja) * 1989-08-25 1997-08-13 キッコーマン株式会社 Ｎ▲上６▼，ｎ▲上６▼―ジ置換―アデノシン―３’，５’―環状リン酸及びその製法
US20040186282A1 (en) * 2003-03-20 2004-09-23 Chait Edward M. Synthesis and method of purification of cyclic nucleotide derivatives

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3225029A (en) * 1962-03-08 1965-12-21 Yamaoka Naotaka Process for the preparation of nucleosides and products obtained thereby
DE1221228B (de) * 1963-09-12 1966-07-21 Hoechst Ag Verfahren zur Herstellung von 5-Joduracil-2' -desoxyribosid-3', 5'-di-Estern
US3300479A (en) * 1965-08-05 1967-01-24 Upjohn Co Deazapurine riboside cyclic 3', 5'-phosphates and process therefor
US3431252A (en) * 1966-04-01 1969-03-04 Merck & Co Inc 5,5-dialkyl-d-ribofuranosyl purine compounds and intermediates
BE738543A (sv) * 1968-09-10 1970-03-09
US3627753A (en) * 1969-12-03 1971-12-14 Anvar Iso-adenosine-3{40 ,5{40 -monophosphoric acid and its salts

Also Published As

Publication number Publication date
JPS5022559B1 (sv) 1975-07-31
SE412240B (sv) 1980-02-25
CA979890A (en) 1975-12-16
US3856776A (en) 1974-12-24
DE2049638A1 (de) 1971-04-15
CH531009A (fr) 1972-11-30
SE7314163L (sv) 1980-02-25
GB1336441A (en) 1973-11-07

Similar Documents

Publication Publication Date Title
SE400296B (sv) Forfarande for framstellning av derivat av cyklisk adenosin-3',5'-monofosforsyra
SE382459B (sv) Forfarande for framstellning av xantonderivat.
SE384211B (sv) Forfarande for framstellning av 2-substituerade-4-amino-6,7,8-trialkoxikinazoliner
SE385585B (sv) Forfarande for framstellning av 1-alkyl-1,4-dihydro-4-oxo-3-kinolinkarboxylsyraderivat
BE758910A (fr) Preparation de dimethyl-2, 2-propanediol-1, 3
DK125794B (da) Analogifremgangsmåde til fremstilling af 2,3-dichlorphenoxyeddikesyrederivater.
SE399427B (sv) Forfarande for framstellning av 2,4 diamino-bensylpyrimidiner
SE385212B (sv) Forfarande for framstellning av farmaceutiskt verdefulla pyrazol-4-ettiksyraderivat
SE385698B (sv) Forfarande for framstellning av kinolinettiksyraderivat
SE380522B (sv) Forfarande for framstellning av (1- (p-klorbensoyl)-5-metoxi-2-metyl-3-indol) - acetoxiettiksyra med antiflogistisk verkan
SE7511680L (sv) Forfarande for framstellning av furanderivat
SE399708B (sv) Forfarande for framstellning av tioxanton-2-karboxylsyraderivat
SE402009B (sv) Forfarande for framstellning av 9-desoxi-prosta-5,9,(10),13-triensyraderivat
SE402451B (sv) Forfarande for framstellning av 14-desoxi-14-acetoximutilin
SE384685B (sv) Forfarande for framstellning av linkomycinderivat
SE380527B (sv) Forfarande for framstellning av 1oh-tieno(3,2-c)(1)-bensazepinderivat
FI52216C (sv) Förfarande för framställning av gamma-piperidinobutyrofenonderivat.
NO144170C (no) Fremgangsmaate til fremstilling av desacetoksy-cefalosporansyrederivater.
DK126203B (da) Analogifremgangsmåde til fremstilling af thiophenddikesyrederivater.
SE404367B (sv) Forfarande for framstellning av derivat av homofolsyra
SE383521B (sv) Forfarande for framstellning av kardenolid-3-(2',3-dedesoxi-2,'3'-oxido-glykosider).
SE381046B (sv) Forfarande for framstellning av 1,4-bensodiazepinderivat
NO136538C (no) Fremgangsm}te for fremstilling av indolderivater
SE396599B (sv) Forfarande for framstellning av 1,2-di-substituerade hydraziner
SE394668B (sv) Forfarande for framstellning av 2-etylhexan-1-al